The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study

被引：0

作者：

Zeineddine, Maya ^{[1
,2
]}

Alroughani, Raed ^{[3
]}

Mohamed, Samar Farouk Ahmed ^{[4
]}

Al Mahdawi, Akram ^{[5
]}

Khoury, Samia ^{[6
]}

El Ayoubi, Nabil ^{[6
]}

Inshasi, Jihad ^{[7
,8
]}

Al Khaboori, Jaber ^{[9
]}

Al-Asmi, Abdullah ^{[10
,11
]}

Gouider, Riadh ^{[12
]}

Aljarallah, Salman ^{[13
]}

Al Khawajah, Nuha Marwan ^{[13
]}

Al Malik, Yaser ^{[14
,15
]}

Abulaban, Ahmad ^{[14
,15
]}

Makkawi, Seraj ^{[14
,15
,16
]}

Khojah, Osama ^{[14
,15
,16
]}

El Hajj, Taghrid ^{[17
]}

Massouh, Joelle ^{[18
]}

Alsalamat, Husam ^{[19
]}

Dimassi, Hani ^{[2
]}

al-hajje, Amal ^{[20
,21
]}

Salameh, Pascale ^{[20
,21
,22
,23
]}

Boumediene, Farid ^{[1
]}

Yamout, Bassem I. ^{[18
]}

机构：

[1] Univ Limoges, CHU Limoges, Inserm,Inst Epidemiol & Trop Neurol,Omega Hlth, U1094,IRD U270,EpiMaCT Epidemiol Chron Dis Trop Z, Limoges, France

[2] Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon

[3] Amiri Hosp, Kuwait, Kuwait

[4] Ibn Sina Hosp, Kuwait, Kuwait

[5] Baghdad Med City Teaching Hosp, Baghdad, Iraq

[6] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Med Ctr, Beirut, Lebanon

[7] Rashid Hosp, MS Dept, Dubai, U Arab Emirates

[8] Dubai Hlth Author, Dubai Med Coll, Dubai, U Arab Emirates

[9] Royal Hosp, Dept Neurol, Muscat, Oman

[10] Sultan Qaboos Univ, Neurol Unit, Dept Med, Coll Med & Hlth Sci, Muscat, Oman

[11] Sultan Qaboos Univ, Sultan Qaboos Univ Hosp, Muscat, Oman

[12] Razi Univ Hosp Mannouba, Clin Invest Ctr Neurosci & Mental Health, Dept Neurol, LR18SP03, Tunsi, Tunisia

[13] Med City, Riyadh, Saudi Arabia

[14] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia

[15] Minist Natl Guard Hlth Affairs, Dept Neurosci, Jeddah, Saudi Arabia

[16] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia

[17] Lebanese Univ, Fac Med Sci, Beirut, Lebanon

[18] Harley St Med Ctr, Neurol Inst, Abu Dhabi, U Arab Emirates

[19] Al Balqa Appl Univ, Fac Med, Al Salt 19117, Jordan

[20] Lebanese Univ, Fac Pharm, Beirut, Lebanon

[21] Natl Inst Publ Hlth Clin Epidemiol & Toxicol INSP, Beirut, Lebanon

[22] Lebanese Amer Univ, Sch Med, Byblos, Lebanon

[23] Univ Nicosia, Sch Med, Dept Primary Care & Populat Hlth, CY-2417 Nicosia, Cyprus

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O096/1296

引用

页码：91 / 92

页数：2

共 50 条

[1] Anti-CD20 and natalizumab in highly active relapsing-remitting multiple sclerosis: the SWIFNA-20 comparative effectiveness study
Laplaud, D. -A.
Rollot, F.
Casey, R.
Wiertlewski, S.
Pelletier, J.
De Seze, J.
Labauge, P.
Ruet, A.
Thouvenot, E.
Ciron, J.
Clavelou, P.
Stankoff, B.
Bourre, B.
Lebrun-Frenay, C.
Maillart, E.
Defer, G.
Camdessanche, J. -P.
Maurousset, A.
Hankiewicz, K.
Bakchine, S.
Montcuquet, A.
Vukusic, S.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 678 - 680
[2] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Rollot, Fabien
Couturier, Justine
Casey, Romain
Wiertlewski, Sandrine
Debouverie, Marc
Pelletier, Jean
De Seze, Jerome
Labauge, Pierre
Ruet, Aurelie
Thouvenot, Eric
Ciron, Jonathan
Berger, Eric
Gout, Olivier
Clavelou, Pierre
Stankoff, Bruno
Casez, Olivier
Bourre, Bertrand
Zephir, Helene
Moreau, Thibault
Lebrun-Frenay, Christine
Maillart, Elisabeth
Edan, Gilles
Neau, Jean-Philippe
Montcuquet, Alexis
Cabre, Philippe
Camdessanche, Jean-Philippe
Defer, Gilles
Ben Nasr, Haifa
Maurousset, Aude
Hankiewicz, Karolina
Pottier, Corinne
Leray, Emmanuelle
Vukusic, Sandra
Laplaud, David-Axel
NEUROTHERAPEUTICS, 2022, 19 (02) : 476 - 490
[3] The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis
Asha, Mohammad Z., I
Al-Asaad, Yousef
Khalil, Sundos F. H.
IBRO NEUROSCIENCE REPORTS, 2021, 11 : 103 - 111
[4] The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
Curti, Erica
Tsantes, Elena
Baldi, Eleonora
Caniatti, Luisa Maria
Ferraro, Diana
Sola, Patrizia
Granella, Franco
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 146 - 152
[5] Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review
Brown, Justin D.
Muston, Benjamin T.
Massey, Jennifer
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 86
[6] Real-world evidence of anti-CD20 monoclonal antibodies in chilean patients with multiple sclerosis
Del-Canto, A.
Garcia, L.
Aylwin, E.
Jurgensen-Heinrich, L.
Guzman-Carcamo, I.
Gutierrez-Calquin, L.
Barrera-Hormazabal, A.
Cruz, J. P.
Bravo-Grau, S.
Pelayo, C.
Soler, B.
Uribe-San-Martin, R.
Carcamo, C.
Ciampi, E.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 383 - 384
[7] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot
Justine Couturier
Romain Casey
Sandrine Wiertlewski
Marc Debouverie
Jean Pelletier
Jérôme De Sèze
Pierre Labauge
Aurélie Ruet
Eric Thouvenot
Jonathan Ciron
Eric Berger
Olivier Gout
Pierre Clavelou
Bruno Stankoff
Olivier Casez
Bertrand Bourre
Hélène Zephir
Thibault Moreau
Christine Lebrun-Frenay
Elisabeth Maillart
Gilles Edan
Jean-Philippe Neau
Alexis Montcuquet
Philippe Cabre
Jean-Philippe Camdessanché
Gilles Defer
Haifa Ben Nasr
Aude Maurousset
Karolina Hankiewicz
Corinne Pottier
Emmanuelle Leray
Sandra Vukusic
David-Axel Laplaud
Neurotherapeutics, 2022, 19 : 476 - 490
[8] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
Finn Sellebjerg
Morten Blinkenberg
Per Soelberg Sorensen
CNS Drugs, 2020, 34 : 269 - 280
[9] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
Sellebjerg, Finn
Blinkenberg, Morten
Sorensen, Per Soelberg
CNS DRUGS, 2020, 34 (03) : 269 - 280
[10] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Cavit Boz
Serkan Ozakbas
Murat Terzi
Rana Karabudak
Serhan Sevim
Recai Turkoglu
Aysun Soysal
Belgin Petek Balcı
Hüsnü Efendi
Ömer Faruk Turan
Nur Yüceyar
Mehmet Fatih Yetkin
Serap Zengin Karahan
Meltem Demirkıran
Sibel Guler
Kadriye Agan
Nefati Kıylıoğlu
Cavid Baba
Asli Tuncer
Mesrure Köseoğlu
Neurological Sciences, 2023, 44 : 2121 - 2129

← 1 2 3 4 5 →